𝔖 Bobbio Scriptorium
✦   LIBER   ✦

9149 Phase II study of bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (p) with metastatic non squamous non-small-cell lung cancer (NSCLC)

✍ Scribed by Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mon, M. Álvarez; Sánchez-Hernández, A.; Gallego, R.; Torrego, J.C.


Book ID
122877788
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
49 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES